The Dark Side of Powerful Medicines
Many of the most effective drugs in psychiatry and general medicine carry a hidden risk: they can provoke akathisia, a tormenting restlessness that can make patients fear the very pills meant to heal them.
Antipsychotics at the Center
Antipsychotic medications are the leading culprits. These drugs are used to treat conditions like schizophrenia and severe mood disorders. They work largely by blocking dopamine receptors, altering the brain’s chemical signaling.
This dopamine blockade is closely tied to movement side effects, known collectively as extrapyramidal symptoms. Akathisia is one of these – and one of the hardest to bear. First-generation (older) antipsychotics are particularly notorious, with about one in four people who take them developing akathisia. Second-generation (newer) antipsychotics generally pose a lower risk, but not a zero one.
It’s Not Just Antipsychotics
Surprisingly, a wide range of medications can set off akathisia:
- Antidepressants, especially selective serotonin reuptake inhibitors (SSRIs)
- The anti-nausea drug metoclopramide
- The older drug reserpine
- Some calcium channel blockers, antibiotics, and anti-vertigo medications
Any drug that lists “agitation” as a side effect may, in some cases, be provoking unrecognized akathisia.
The Antidepressant Puzzle
When antidepressants are involved, clinicians often talk about an “activation syndrome” – a state of increased energy, agitation, and sometimes anxiety that can emerge early in treatment. Akathisia may be included as one component of this syndrome, but the two are not identical.
Antipsychotic-induced akathisia is linked to a known neuroreceptor mechanism, such as dopamine-receptor blockade. With antidepressants, the boundary between general activation and true akathisia is fuzzier, and experts do not fully agree on how to distinguish them.
When Stopping the Drug Triggers Restlessness
Akathisia is not only a side effect of taking medication; it can also arise when medication is stopped. Withdrawal in drug-dependent individuals can bring on the same intense restlessness, turning the process of getting off a drug into another ordeal.
Mislabeling and Hidden Cases
In antidepressant trials, akathisia has sometimes been miscoded under softer terms like “agitation,” “emotional lability,” or “hyperkinesis” (overactivity). Restlessness that was classed simply as dyskinesia – abnormal movements – may in fact have been unrecognized akathisia, buried in the data.
The Takeaway
Powerful medications can save lives, but they can also unleash akathisia, a side effect so distressing that people may abandon treatment. Understanding which drugs can trigger it – and how easily it can be misnamed – is essential to making modern therapies safer and more humane.